Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer
GSK is buying two near-approval therapies that could challenge lung cancer treatments from Roche, Pfizer and other drugmakers.
Nick Paul Taylor
Jun 9, 2026 4:41am
City lays foundation for RNAi renaissance with nearly $100M
Jun 8, 2026 4:00pm
How AI is reshaping biopharma decision-making
Brought to you by
Clarivate
Treeline sees path to public markets via reverse merger
Jun 8, 2026 10:37am
Managing complexity across biopharma modalities
Brought to you by
SK Pharmteco
J&J makes $1B bet on emerging DAC space by netting Firefly Bio
Jun 8, 2026 10:05am
